๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cyclophosphamide therapy in patients with advancing breast cancer following adrenalectomy and 5-fluorouracil

โœ Scribed by Anthony J. Piro; Richard E. Wilson; Hans B. Nevinny

Publisher
John Wiley and Sons
Year
1971
Tongue
English
Weight
334 KB
Volume
27
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cyclophosphamide versus cyclophosphamide
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial
โœ Hyman B. Muss; Virginia Howard; Frederick Richards Ii; Douglas R. White; Don V. ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 364 KB ๐Ÿ‘ 1 views

Thirty-two evaluable patients with metastatic carcinoma of the prostate were entered into a prospective randomized trial comparing cyclophosphamide (CYC) with a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF). Progressive disease after endocrine manipulation was noted in 97% (3

5-fluorouracil with leucovorin in breast
5-fluorouracil with leucovorin in breast cancer
โœ Charles L. Loprinzi ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 247 KB

Extensive preclinical data have demonstrated that leucovorin can modulate 5-fluorouracil (5-FU) cytotoxicity. Additionally, randomized clinical trials have shown that leucovorin increases the therapeutic index of 5-FU in patients with advanced colorectal cancer, setting a new therapeutic standard fo